Two different dosages of nebulized steroid versus parenteral steroid in the management of COPD exacerbations: A randomized control trial

Medical Science Monitor

Volumn 20, Issue , 2014, Pages 513-520

  Ucar, Elif Yilmazel ^a   Araz, Omer ^a   Meral, Mehmet ^a   Sonkaya, Esin ^a   Saglam, Leyla ^a   Kaynar, Hasan ^a   Gorguner, Ali Metin ^a   Akgun, Metin ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Budesonide Therapeutic use; Chronic Obstructive Drug therapy; Methylprednisolone Therapeutic use; Pulmonary Disease

Indexed keywords

AMINOPHYLLINE; BUDESONIDE; CORTICOSTEROID; IPRATROPIUM BROMIDE; METHYLPREDNISOLONE; PULMICORT NEBUAMPUL; SALBUTAMOL; UNCLASSIFIED DRUG;

AGED; AIRWAY OBSTRUCTION; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN SATURATION; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD CELL COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL NEBULIZER; OXYGEN THERAPY; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; THRUSH;

ADMINISTRATION, INHALATION; AGED; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, PARENTERAL; MALE; NEBULIZERS AND VAPORIZERS; OXYGEN; PARTIAL PRESSURE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STEROIDS;

EID: 84897446515     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.890210     Document Type: Article

References (28)

1. Rosenberg SR, Kalhan R: An integrated approach to the medical treatment of chronic obstructive pulmonary disease. Med Clin N Am, 2012; 96: 811-26
2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. (Updated 2010). Available at: http://www.goldcopd.org Date last accessed; December, 27, 2013
3. National Clinical Guideline Centre (UK). Chronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care [Internet], 2010
4. Donaldson GC, Seemungal TA, Bhownik A, Wedzicha JA: Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax, 2002; 57: 847-52
5. Donaldson GC, Seemungal TA, Patel IS et al: Airway and systemic inflammation and decline in lung function in patients with COPD. Chest, 2005; 128: 1995-2004
6. Kwong FK, Sue MA, Klaustermeyer WB: Corticosteroid complications in respiratory disease. Ann Allergy, 1987; 58: 326
7. McEvoy CE, Ensrud KE, Bender E et al: Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1998; 157: 704
8. Decramer M, Lacquet LM, Fagard R, Rogiers P: Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med, 1994; 150: 11
9. Dujovne CA, Azarnoff DL: Clinical complications of corticosteroid therapy. A selected review. Med Clin North Am, 1973; 57: 1331
10. Henzen C, Suter A, Lerch E et al: Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet, 2000; 355: 542-45
11. WalshLJ, Wong CA, Oborne J et al: Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax, 2001; 56: 279-84
12. Walters JA, Gibson PG, Wood-Baker R et al: Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 2009; CD001288
13. Morice AH, Morris D, Lawson-Matthew P: Acomparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease. Clin Pharmacol Ther, 1996; 60: 675-78
14. Maltais F, Ostinelli J, Bourbeau J et al: Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med, 2002; 165: 698-703
15. Mirici A, Meral M, Akgun M: Comparison of the efficacy of nebulized budesonide with parenteral corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Clin Drug Invest, 2003; 23: 55-62
16. Gunen H, Hacievliyagil SS, Yetkin O et al: The role of nebulized budesonide in the treatment of exacerbations of COPD. Eur Respir J, 2007; 29: 660-67
17. Wei H, Xin Z: Nebulised budesonide in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Practical Clin Med Mag 2004. p.3. [Last cited 2004]; Available from: http://www.scholar.ilib.cn/Ajslcyxzz200402003. html
18. Gaude GS, Nemagouda S: Clinical efficacy of nebulized budesonide with parenteral/oral steroids in patients with acute exacerbation of COPD: A prospective study in tertiary care hospital. Lung India, 2009; 26: S11-12
19. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med, 1995; 152: 1107-36
20. Borg G: Psychophysical bases of perceived exertion. Med Sci Sports Exerc, 1982; 14: 377-81
21. Burge S, Wedzicha JA: COPD exacerbations: definitions and classifications. Eur Respir J, 2003; 21: 46-53
22. Niewoehner D, Erbland ML, Deupree RH et al: Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Engl J Med, 1999; 340: 1941-47
23. Seemungal TA, Donaldson GC, Paul EA et al: Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1998; 157: 1418-22
24. Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J et al.; Estudi del Factors de Risc d'Agudització de la MPOC investigators: Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax, 2003; 58: 100-5
25. Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P et al: Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax, 2005; 60: 925-31
26. Levy ML, Stevenson C, Maslen T: Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care. Thorax, 1996; 51: 1087-92
27. Rodrigo GJ: Comparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of adult acute asthma. Am J Respir Crit Care Med, 2005; 171: 1231-36
28. Belda J, Margarit G, Martinez C et al: Anti-inflamatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations. Eur Respir J, 2007; 30: 1143-49